Rafa Laboratories Ltd. (TLV:RAFA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,469.00
-4.00 (-0.27%)
At close: Aug 13, 2026

Rafa Laboratories Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
459.86418.44420.08355.2
Revenue Growth
--0.39%18.27%-
Cost of Revenue
237.04220.33218.88196.91
Gross Profit
222.82198.11201.2158.29
Selling, General & Admin
83.6181.782.0776.62
Research & Development
3.774.084.492.68
Other Operating Expenses
0.660.660.620.69
Operating Expenses
88.0486.4487.1979.98
Operating Income
134.77111.67114.0178.31
Interest Expense
-1.15-0.91-1.22-1.31
Interest & Investment Income
1.380.620.230.13
Earnings From Equity Investments
0.580.01-1.19-2.11
Currency Exchange Gain (Loss)
-2.1-2.1-1.610.32
Other Non Operating Income (Expenses)
0.320.320.24-
EBT Excluding Unusual Items
133.79109.61110.4775.35
Gain (Loss) on Sale of Investments
1.21.2-0.240.38
Pretax Income
135110.81110.2375.73
Income Tax Expense
11.8310.4710.89.51
Net Income
123.16100.3499.4366.22
Net Income to Common
123.16100.3499.4366.22
Net Income Growth
-0.91%50.16%-
Shares Outstanding (Basic)
2,8552,8672,9242,879
Shares Outstanding (Diluted)
2,8552,9512,9243,010
Shares Change
-0.91%-2.84%-
EPS (Basic)
0.040.040.030.02
EPS (Diluted)
0.040.030.030.02
EPS Growth
-0%54.55%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
111.3895.15135.7133.16
Free Cash Flow Per Share
0.040.030.050.01
Gross Margin
48.45%47.34%47.89%44.56%
Operating Margin
29.31%26.69%27.14%22.05%
Profit Margin
26.78%23.98%23.67%18.64%
Free Cash Flow Margin
24.22%22.74%32.30%9.34%
EBITDA
144.19120.85122.5990.14
EBITDA Margin
31.36%28.88%29.18%25.38%
D&A For EBITDA
9.429.198.5711.83
EBIT
134.77111.67114.0178.31
EBIT Margin
29.31%26.69%27.14%22.05%
Effective Tax Rate
8.77%9.45%9.80%12.56%
Advertising Expenses
-14.3115.7713.82